Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/15/2009WO2009033790A3 Use of a peptide as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2008104620A8 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments
10/15/2009WO2006108135A9 Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways
10/15/2009US20090259025 Lactoferrin
10/15/2009US20090259021 Liquid Phase Peptide Synthesis of KL-4 Pulmonary Surfactant
10/15/2009US20090259019 Masp-2, a complement fixing enzyme, and uses for it
10/15/2009US20090258930 Double stranded rna structures and constructs, and methods for generating and using the same
10/15/2009US20090258927 Method for the Modulation of Function of Transcription Factors
10/15/2009US20090258834 Plasma protein-binding ligands
10/15/2009US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity
10/15/2009US20090258831 Treatment using neublastin polypeptides
10/15/2009US20090258830 Diagnostic and therapeutic uses of gelsolin in renal failure
10/15/2009US20090258829 New formulation for increasing bioavailability of neurturin
10/15/2009US20090258828 Investigation of mucosa dryness conditions
10/15/2009US20090258827 Transcription Factor Modulator
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258825 HOPM1 Mediated disease resistance to Pseudomonas syringae in Arabidopsis
10/15/2009US20090258824 Amyloid beta receptor and uses thereof
10/15/2009US20090258823 Composition and methods for the prevention and treatment of gastrointestinal infections
10/15/2009US20090258822 Diagnosis and Treatment of Age-Related Macular Degeneration
10/15/2009US20090258821 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
10/15/2009US20090258820 Echinocandin/carbohydrate complexes
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258818 Compositions For the Treatment of Diabetes
10/15/2009US20090258817 Arylsulfanyl compounds and compositions for delivering active agents
10/15/2009US20090258816 Use of gpcr agonists to delay progression of diabetes
10/15/2009US20090258815 Antiviral peptide and antiviral agent
10/15/2009US20090258814 Method for treating a synucleinopathy
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258357 identifying a binding partner to a cytokine receptor common gamma chain like (CRCGCL) polypeptide encoded by a cDNA; for diagnosis and treatment autoimmune disorders
10/15/2009US20090258070 Topical LFA-1 antagonists for use in localized treatment of immune related disorders
10/15/2009US20090258058 Novel silicone film former for delivery of actives
10/15/2009US20090258056 Systems and methods for preparing autologous fibrin glue
10/15/2009US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
10/15/2009US20090258031 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response
10/15/2009US20090258030 Materials and Methods for Improving Livestock Productivity
10/15/2009US20090258028 Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
10/15/2009US20090258024 Compositions and methods for diagnosis and treatment of chronic inflammatory diseases
10/15/2009US20090258023 Tgf-beta superfamily binding proteins and modulation of bone formation and loss
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090258015 Modulators of Candida Hyphal Morphogenesis and Uses Thereof
10/15/2009US20090258005 Therapeutic compositions and methods
10/15/2009US20090258004 Human blood proteins expressed in monocot seeds
10/15/2009US20090258000 Mucosally non-irritative amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
10/15/2009US20090257999 Method of preventing contrast-induced nephropathy
10/15/2009US20090257998 Method for treating heart attacks, strokes and diabetic crisis by utilizing modified virus virions to insert necessary protein molecules and vital nutrients into targeted cells
10/15/2009US20090257997 Stable Aqueous Compositions Comprising Bioactive Creatine Species
10/15/2009US20090257989 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells
10/15/2009US20090257981 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
10/15/2009US20090257980 Anti-virus therapy for respiratory diseases
10/15/2009US20090257979 Novel Inhibitors of Hepatitis C Virus Replication
10/15/2009US20090257978 Antiviral coumpounds
10/15/2009US20090257977 Novel tetrahydropyridothiophenes
10/15/2009US20090257954 Development of a simple animal model for infection by viruses and other obligate intracellular parasites
10/15/2009US20090257952 Engineered Integrin Binding Peptides
10/15/2009US20090257951 NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same
10/15/2009US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
10/15/2009CA2758023A1 Commensal bacteria as signal mediators within a mammalian host
10/15/2009CA2720864A1 Compositions useful for the treatment of diabetes and other chronic disorder
10/15/2009CA2720721A1 Combination therapy for the treatment of bacterial infections
10/15/2009CA2720617A1 Modified cpn10 and prr signalling
10/15/2009CA2720616A1 Treatment of tumours
10/15/2009CA2720614A1 Neutralization of gm-csf for the treatment of heart failure
10/15/2009CA2719531A1 New ruthenium complexes as catalysts for metathesis reactions
10/15/2009CA2710554A1 Methods and compositions related to internalizing rgd peptides
10/15/2009CA2707448A1 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities
10/14/2009EP2108698A1 Vascular endothelial cell-binding peptide
10/14/2009EP2108659A1 Virally safe factor VIII with a low content of higher multimers
10/14/2009EP2108658A1 Uses of IL-23 agonists and antagonists; related reagents
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108377A1 Vascularization inhibitors
10/14/2009EP2108376A2 Prevention and treatment of amyloidogenic disease
10/14/2009EP2108373A1 Treatment of tumor metastases
10/14/2009EP2108372A1 Novel antimicrobial peptides
10/14/2009EP2108368A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker
10/14/2009EP2108363A1 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same
10/14/2009EP2108046A2 Fviii-independent fix-mutant proteins for hemophilia a treatment
10/14/2009EP1959985B1 Use of prolactin in the prophylactic treatment of cancer
10/14/2009EP1871798B1 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
10/14/2009EP1694702B1 Methods of inducing il-10 production
10/14/2009EP1664108B1 Separation of polypeptides comprising a racemized amino acid
10/14/2009EP1664096B1 Antimicrobial polypeptides
10/14/2009EP1558747B1 Glycoprotein synthesis
10/14/2009EP1474158B1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
10/14/2009EP1450845B1 15603, a human ion channel family member
10/14/2009EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
10/14/2009EP1372710B1 Mva expressing modified hiv envelope, gag, and pol genes
10/14/2009EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery
10/14/2009EP1292325B1 Matrix protein compositions for dentin regeneration
10/14/2009EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009EP1230268B1 Heteroclitic analogs of class i epitopes
10/14/2009EP1180686B1 Remedies for kidney diseases and method for screening the same
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP1144447B1 Tuberculosis diagnostic test
10/14/2009EP0830377B1 Glucagon-like peptide-2 and its therapeutic use
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
10/14/2009CN101558080A Modulation of angiogenesis by a-beta peptide fragments
10/14/2009CN101557827A Pharmaceutical compositions comprising HGH for oral delivery
1 ... 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 ... 3163